About the Heart Attack Prevention Clinic photos

What is the Bale Method
Bale Method Brochure

Are you at risk?
To find out call (509) 747-8000


Bradley Field Bale, M.D.
Bradley Field Bale, M.D.
Curriculum Vitae


Amy L. Doneen, RN, BSN, MSN, A.R.N.P
Amy L. Doneen, RN, BSN, MSN, A.R.N.P
Curriculum Vitae


Bill Gray, MD
Bill Gray, MD
nav
Home Page
link

nav
Stats
link
nav

Risk
link
nav

News
link
nav

About
link
nav

Contact
link
nav
 
Amy L. Doneen, RN, BSN, MSN, A.R.N.P
Director
Heart Attack & Stroke Prevention Center
801 W. 5th Suite #317
Spokane, WA. 99204
Office: (509) 747-8000
Fax: (509)747-8051
Cell: (509) 953-3377
adoneen@heartattackzone.com
Amy L. Doneen, RN, BSN, MSN, A.R.N.P


Honors and recognition:
  • Co-Chair of National 5-hour CME program addressing residual risk in CV disease. Development and delivery of program to 20 major US cities in 2008.
  • Chair of the Pacific Northwest Preventative Cardiovascular Nurses Association 2007
  • Principle Instructor of the Bale/Doneen Preceptorship 40 hour CME program 2006/2007.
  • Presentation at the European Atherosclerosis Society 76th annual conference in Helsinki, Finland on June 10, 2007.
  • Member of 4 person National committee for the development and allocation of a National CME grand round presentation on metabolic syndrome - Grundy, Sacks, Doneen, Kountz - 2007.
  • International board member of DeCODE genetics, investigating the role of genetics in the clinical arena.
  • Presentation at the 6th Annual Atherosclerosis and Vascular Biology Conference 2005
  • Oral Podium Presentation at the International Symposium of Atherosclerosis, Rome, Italy 2006
  • Graduating Summa Cum Laude, Gonzaga University


ARNP License: AP30006482 WA
RN Nursing License: RN 00117584 WA

Thesis Study and Title: "The Relationship between Electron Beam Computed Tomography Calcium Scores and established Clinical and Serologic risk factors for Coronary Artery Disease"

Published Work:
  1. Carotid Intima-media thickness augments Framingham scoring in assessing CV risk in metabolic syndrome patients - accepted for presentation at the EAS Helsinki Finland June 10, 2007.
  2. Effect of aggressive CV risk factor management on lipoproteins and carotid intima-media thickness in patients with metabolic patients - accepted for presentation at the EAS Helsinki Finland, June 10, 2007.
  3. The Effectiveness of Multiple Interventions on Carotid Artery Atherosclerosis in a Clinical Setting. Published and accepted for presentation at the 6th Annual Conference on Arteriosclerosis, Thrombosis, and Vascular Biology. Washington, DC. April 28-30, 2005.
  4. Aggressive risk factor modification in patients with sub-clinical atherosclerosis reduces plaque burden and regresses carotid artery wall thickness. Bale BF, Doneen AL, Drueding R, Charland SL. Atherosclerosis 2006;7(3):161
  5. Carotid intima-media thickness testing identifies at risk patients missed by Framingham 10-year risk scoring. Doneen AL, Bale BF, Charland SL, Smith TF. Atherosclerosis 2006;7(3):324
  6. Vascular Disease in Women: Rumor vs. Reality. Northwest Woman, Feb/Mar 2006.
  7. Stroke, Are you at Risk? Northwest Woman, June/July 2006.
  8. The Relationship between Electron Beam Computed Tomography Calcium Scores and established Clinical and Serologic Risk Factors for Coronary Artery Disease. Published 4/03, University Press.


Employment:
2006: Owner and Medical Director of The Heart Attack & Stroke Prevention Center, Spokane, Washington
1999: Co-founder, The Heart Attack Prevention Clinic, partnership with Dr. Bradley Bale, Spokane, Washington.

Professional Education:
  • Jan. '99 - May '03 Gonzaga University: BSN/MSN/ARNP
  • Sept. '92 - June '94 Spokane Community College: ADN - RN
  • Sept. '90 - June '91 Eastern Washington University: General Studies
  • Sept. '88 - June '90 Western Washington University: General Studies


Area of Professional Focus:
My clinical expertise focuses around advanced cardiovascular risk assessment and aggressive preventative treatment for atherosclerosis, encompassing myocardial infarction prevention and ischemic stroke prevention and diabetes prevention in the primary and secondary population. My risk assessment includes, but is not limited to: Lipid testing, inflammatory marker identification, subparticle measurements, nutrigenomics, genetic risk identification, IMT (Intima Media Thickness Testing), ABI, AAA screening, and Coronary CT for structural assessment, along with identification and treatment of insulin resistance and metabolic syndrome. I take a focused interest in coronary heart disease and women. I am committed to educating the public about heart attack prevention and share my knowledge with other providers to make an international impact on changing the paradigm of treatment to a model of evidenced-based/outcome-based prevention.

Professional Activities:
  1. Member of the American Heart Association.
  2. Member of the American Stroke Association.
  3. Member of the Council on Arteriosclerosis, Thrombosis, and Vascular Biology.
  4. Member of the National Lipid Association.
  5. Chair of the Pacific Northwest chapter of the Preventative Cardiovascular Nurses Association
  6. Co-founder of the Heart Attack Prevention Clinic and The Bale/Doneen Method of CHD Prevention in partnership with Dr. Bradley Bale, MD.
  7. Active member of Sigma Theta Tau International; a nursing honor society focused on nursing research and nursing education.
  8. Nurse Practitioner Group of Spokane; a monthly continuing educational seminar forum.
  9. Member of steering committee for "Healthy U" at Deaconess Medical Center.


Professional Speaking opportunities:
  1. Sponsorship by Glaxo Smith Kline pharmaceutical's speaking bureau.
  2. Sponsorship by DeCode Genetics - clinical application.
  3. Sponsorship by Bristol-Myers Squibb's speaking bureau.
  4. Sponsorship by KOS pharmaceuticals, "Treating atherosclerosis with Polypharmacy".
  5. Sponsorship by Abbott pharmaceutical's speaking bureau.
  6. Sponsorship by KING pharmaceutical's speaking bureau.
  7. Sponsorship by AstraZeneca's speaking bureau.
  8. Sponsorship by Diadexus' speaking bureau for Lp-PLAC-2.
  9. Sponsorship by CardioRisk's speaking bureau for CIMT testing.
  10. Public speaking/key-note speaker focusing on women's heart health and heart attack prevention.
  11. Key note speaker West Texas Cardiac Symposium 2007.
  12. Key note speaker West Texas Women's Health Symposium 2007
  13. Appearances on KXLY Good Morning Northwest News Program focusing on women and heart disease.
  14. Guest appearances on KXLY 99.9 radio discussing women and heart disease.
  15. Speaker at Cheyenne Wyoming's American Heart Disease luncheon for Women.
  16. Key note speaker at the California state NP meeting in San Diego, CA.
  17. Key note speaker at the Washington State association of CV nurses.
  18. Numerous speaking engagements focused on heart disease, metabolic syndrome, and polypharmacy directed at physicians, nurse practitioners, pharmacists, physician assistants, and medical staff.
  19. Keynote speaker for the annual conference for laboratory technicians, focused on the event reality of arteriosclerosis and the various advanced laboratory identification techniques of disease and structural evidence of disease.
  20. Keynote speaker at the First Annual Cardiovascular Symposium at St. James Heart & Vascular Institute, Tinley Park, IL.
  21. Grand rounds at St. James hospital cardiology, Tinley Park, IL.
  22. Grand rounds at Sacred Heart Hospital, Spokane, Wa.
  23. A tour of Montana, focused at physicians and pharmacists to emphasize the importance of polypharmacy in the management of arteriosclerosis (sponsored by BMS).
  24. Sponsorship by Abbott, use of fibrates in patients with insulin resistance and metabolic syndrome.
  25. Speaking at Spokane's Nurse Practitioner Group, keynote speaker for CME at their annual end-of-the year meeting 2005.
  26. Week long tour of Texas (July 2004 and January 2006) speaking with physicians, nurse practitioners, and physician assistants about identification and treatment of metabolic syndrome and insulin resistance (Sponsored by KOS).
  27. Poster presentation of our 2004 data at the annual Atherosclerosis, Thrombosis, and Vascular Biology Conference with the AHA in Washington DC in April 2004.
  28. Grand Rounds Sacred Heart Hospital December 2005 - insulin resistance & Metabolic Syndrome.
  29. Tour of Texas (2/8/06-2/12/06) co-presentation with Dr. Annie Varughese from Texas Heart Institute - focusing on Women's Heart Health and Prevention.
  30. Speaker at the Women's Health Show - Spokane, WA 3/18 and 3/19 at Convention Center.
  31. Speaker - "Heart's Content" - Davenport WA and Odessa WA 2/24 and 2/26/06
  32. Key note speaker at the Wyoming state NP/PA association.
  33. Speaker at the Sacred Heart Women's show 2006 - "Know your risk".
  34. Invited speaker at the Washington State Academy of Physician Assistants; "Metabolic Syndrome", Oct 6, 2006 in Spokane WA.
  35. Speaker - podium presentation at the International Society of Atherosclerosis Rome, Italy. June 2006
 
nav
Subscribe to our News Alerts

Home | Statistics | Risk Assessment | News | About HAPC | Contact Us | Sitemap | Links
Copyright © Heart Attack Prevention Clinic 2003-2008 - Designed by Shortbird Multimedia

nav